Vedolizumab and ustekinumab exposed pregnancies reported from the PIANO registry

Researchers affiliated with the Pregnancy Inflammatory bowel disease And Neonatal Outcomes (PIANO) registry have published a study of pregnancy and infant outcomes following maternal vedolizumab and ustekinumab use in pregnancy. More information can be found here.